Is CEA Better than CYFRA 21-1 in the Monitoring of Squamous Cell Lung Cancer Progression?

Publisher： Karger

E-ISSN： 1423-0151|20|2|200-200

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.20, Iss.2, 2011-01, pp. : 200-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Evaluation of Cyfra 21-1: A Potential Tumor Marker for Non-Small Cell Lung Carcinomas

By Karnak D.   Ulubay G.   Kayacan O.   Beder S.   İbis E.   Oflaz G.  

Lung, Vol. 179, Iss. 1, 2001-01 ,pp. : 57-65

Springer Publishing Company

Access to resources Recommend Favorite

Squamous Cell Carcinoma Antigen in Lung Cancer and Nonmalignant Respiratory Diseases

By Kagohashi Katsunori  

Lung, Vol. 186, Iss. 5, 2008-10 ,pp. : 323-326

Springer Publishing Company

Access to resources Recommend Favorite

ALK‐rearranged squamous cell carcinoma of the lung

By  

Respirology Case Reports, Vol. 3, Iss. 3, 2015-09 ,pp. : 105-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Verrucous Squamous Cell Cancer in the Esophagus: An Obscure Diagnosis

By  

Case Reports in Gastroenterology, Vol. 10, Iss. 2, 2016-08 ,pp. : 466-471

Karger

Access to resources Recommend Favorite

Tissue Polypeptide Specific Antigen and Squamous Cell Carcinoma Antigen for Early Prediction of Recurrence in Lung Squamous Cell Carcinoma

By Ho Y.-J.   Hsieh J.-F.   Tasi S.-C.   Lee J.-K.   Kao C.-H.  

Lung, Vol. 178, Iss. 2, 2000-03 ,pp. : 75-80

Springer Publishing Company

Access to resources Recommend Favorite